# Investigation of PDE5 effect on NOS in nasal polyp pathophysiology

**Authors:** Vahit Mutlu, Zülküf Kaya, Zekai Halıcı, Ayşegül Tavacı Özçelik, Abdullah Serdar Topatan

PMC · DOI: 10.1007/s00405-025-09362-4 · European Archives of Oto-Rhino-Laryngology · 2025-04-05

## TL;DR

This study explores how PDE5 and nitric oxide synthases contribute to nasal polyp development and inflammation.

## Contribution

The study provides new insights into the role of PDE5, iNOS, and eNOS in nasal polyp pathophysiology.

## Key findings

- PDE5 levels were significantly lower in nasal polyp tissues compared to controls.
- iNOS and eNOS levels were significantly higher in nasal polyp tissues.
- These findings suggest a potential link between PDE5, NOS enzymes, and nasal polyp inflammation.

## Abstract

Nasal polyps are masses resulting from chronic mucosal inflammation. Nitric oxide (NO) has recently attracted attention in nasal polyps as it plays an important role in both acute and chronic inflammation. One of the important mechanisms controlling NO production is phosphodiesterase (PDE) enzymes. The enzyme phosphodiesterase type 5 (PDE5) is an important regulator of cyclic guanosine 3‘-5’-monophosphate (cGMP) signalling. PDE5 inhibitors increase intracellular cGMP concentration by inhibiting cGMP degradation and prolong NO signalling. NO is thought to cause nasal congestion because it increases microvascular permeability and causes mucosal oedema. The aim of our study was to investigate the role of PDE5, inducible nitric oxide synthase (iNOS), and endothelial nitric oxide synthase (eNOS) in the pathophysiology of nasal polyps with mucosal oedema in histopathology.

Nasal mucosal tissues were obtained from 25 patients with nasal polyps who underwent endoscopic sinus surgery as the study group and 25 patients who underwent rhinoplasty as the control group. eNOS, iNOS and PDE5 levels were measured in nasal mucosal tissues.

The mean age was 47.40 ± 16.33 years in the nasal polyp group and 35.44 ± 12.47 years in the normal group, and 64.0% (n = 16) of both groups were male. ELISA measurements showed that PDE5 levels were significantly decreased and iNOS and eNOS levels were significantly increased in the nasal polyp group compared with the control group.

This study suggest that iNOS, eNOS, and PDE5 may play important roles in the pathophysiology of nasal polyps.

## Linked entities

- **Proteins:** PDE5A (phosphodiesterase 5A), NOS2 (nitric oxide synthase 2), NOS3 (nitric oxide synthase 3)
- **Chemicals:** nitric oxide (PubChem CID 145068), cyclic guanosine 3'-5'-monophosphate (PubChem CID 135398570), cGMP (PubChem CID 135398570)

## Full-text entities

- **Genes:** NOS3 (nitric oxide synthase 3) [NCBI Gene 4846] {aka EC-NOS, ECNOS, MYMY8, NOSIII, cNOS, eNOS}, PDE5A (phosphodiesterase 5A) [NCBI Gene 8654] {aka CGB-PDE, CN5A, PDE5}, NOS2 (nitric oxide synthase 2) [NCBI Gene 4843] {aka HEP-NOS, INOS, NOS, NOS2A}
- **Diseases:** acute and chronic inflammation (MESH:D007249), mucosal oedema (MESH:C536897), Nasal polyps (MESH:D009298), nasal congestion (MESH:D009668)
- **Chemicals:** NO (MESH:D009569), cGMP (MESH:D006152)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12055634/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12055634/full.md

## References

8 references — full list in the complete paper: https://tomesphere.com/paper/PMC12055634/full.md

---
Source: https://tomesphere.com/paper/PMC12055634